Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study
30. Oktober 2024 08:30 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
NVO Lead Plaintiff Deadline Reminder: Hagens Berman Reminds Novo Nordisk Investors of March 13, 2017 Lead Plaintiff Deadline
06. März 2017 14:14 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, March 06, 2017 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Novo Nordisk A/S (NYSE:NVO) of the March 13, 2017 Lead Plaintiff deadline. If you purchased or...
NVO DEADLINE NOTICE: Rosen Law Firm Reminds Novo Nordisk A/S Investors of Important March 13 Deadline in Class Action – NVO
02. März 2017 18:18 ET
|
The Rosen Law Firm PA
NEW YORK, March 02, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Novo Nordisk A/S securities (NYSE: NVO) from April 30, 2015 through October 27,...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Novo Nordisk A/S – NVO
07. Februar 2017 12:33 ET
|
The Rosen Law Firm PA
NEW YORK, Feb. 07, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Novo Nordisk A/S securities...
LESS THAN 2 MONTHS REMAIN FOR NOVO NORDISK A/S INVESTORS: Hagens Berman Alerts Novo Nordisk Investors to Expanded Class Period and Reminds Them of Lead Plaintiff Deadline
24. Januar 2017 09:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 24, 2017 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Novo Nordisk A/S (NYSE:NVO) to the expanded class period and reminds them of the March 13, 2017...
2 MONTHS REMAIN FOR NOVO NORDISK A/S INVESTORS: Hagens Berman Alerts Novo Nordisk Investors to Securities Class Action and Lead Plaintiff Deadline
12. Januar 2017 15:00 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 12, 2017 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Novo Nordisk A/S (NYSE:NVO) to the securities class action lawsuit filed in the U.S. District...